ArticleESMO gastrointestinal oncology2026
ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy-phase II investigator-initiated trial (NCCH2412/MK015).
H Fujii et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.